News & Events
News & Events
April 26, 2018
CPTR Newsletter – April 2018CPTR Newsletter – April 2018 In this issue: ReSeqTB to be Adopted for WHO Surveillance of Drug-Resistant TB New Collaborations Expand TB-PACTS Database and Leverage Data for Analyses CPTR Workgroup Works to Advance Regulatory Qualification of LAM, a Promising New Biomarker TB-PBPK Model Progresses Toward EMA and FDA Qualification TB-ReFLECT Update: A Collaborative Effort...
April 25, 2018
Ninth Annual Patient-Reported Outcome Consortium WorkshopWHAT: Ninth Annual Patient-Reported Outcome Consortium Workshop WHEN: April 25-26, 2018 WHERE: Sheraton Silver Spring, Silver Spring, MD CONTENT: The Ninth Annual Patient-Reported Outcome Consortium Workshop will be on Wednesday, April 25 and Thursday, April 26, 2018 at the Sheraton Silver Spring, in Silver Spring MD. A detailed agenda and logistics are currently being developed and...
April 16, 2018
Helmsley Charitable Trust Awards Critical Path Institute a Grant to Focus on Crohn’s Disease BiomarkersTucson, AZ, and New York, NY – April 16, 2018 — The Leona M. and Harry B. Helmsley Charitable Trust has awarded Critical Path Institute (C-Path) a grant to support a Crohn’s disease biomarker pre-consortium. The pre-consortium will identify unmet needs for the use of biomarkers in developing new treatments for people with Crohn’s disease. Currently,...
April 11, 2018
2018 Annual International Neonatal Scientific WorkshopYou are cordially invited to participate in the 2018 Annual International Neonatal Scientific Workshop at the Bethesda North Marriott Hotel and Conference Center on April 11th and 12th, 2018. Workshop participants will consider the role for ‘Real-World Evidence’ on medical product development for neonates, examine the regulatory implications of nutritional influences on outcomes of preterm...
March 28, 2018
C-Path and CHDI launch consortium to accelerate development of Huntington’s disease therapiesTucson, AZ, and New York, NY – March 28, 2018 – The Critical Path Institute (C-Path), together with CHDI Foundation, Inc. (CHDI), today announced the official launch of C-Path’s Huntington’s Disease Regulatory Science Consortium (HD-RSC). In addition to these cofounders, the consortium also includes more than 20 different member organizations, including industry partners,...